See the difference small changes can make with CGM*1.

If you're ready to begin managing your diabetes with more confidence*1 — and without fingersticks — the FreeStyle Libre sytems can help.

CGM = continuous glucose monitor(ing)

Woman wearing a FreeStyle Libre continuous glucose monitoring (CGM) sensor and carrying two children
Woman wearing a FreeStyle Libre continuous glucose monitoring (CGM) sensor and carrying two children
Woman wearing a FreeStyle Libre continuous glucose monitoring (CGM) sensor and carrying two children

Get knowledge that can help you make real progress*1.

The FreeStyle Libre systems provide real-time glucose readings with a glance at your smartphone. You'll know when glucose is too low, too high, or right where it should be so you can make more confident choices*1.

Manage your diabetes with more confidence*1.

Get glucose readings in real time§.

Lower your A1C*2,II3 without fingersticks.

You'll know if your glucose levels are too high, too low, or right where they should be—allowing you to make informed choices*1, no fingersticks required.

Stay in the moment.

Easily see your glucose levels, where they’re going, and where they’ve been.

It starts with a prescription.

Why wait any longer? Talk to your healthcare provider. This simple discussion guide can help you get the conversation started.

Real insights from real people who use FreeStyle Libre systems.

 

Scott has Type 1 diabetes and was worried about spikes in his A1C.

“The thing that's most powerful is the data it gives me.”

Courtney has Type 2 diabetes and found monitoring her glucose with fingersticks difficult.

“The data I was able to get now brought light to what was really going on.”

Lexi, her mother, and grandmother are grateful to have technology and each other in their diabetes journey.

“The FreeStyle Libre 3 system … helped my family take charge of our lives with diabetes.”

Chelsee has Type 1 diabetes and found it stressful to manage with an active schedule.

“The FreeStyle Libre 3 system allows me to go through my day without constantly pricking my finger.”

The views expressed should not be used for medical diagnosis or treatment or as a substitute for professional medical advice. Individual symptoms, situations and circumstances may vary.

Affordability

The more affordable CGMs¶4

More people pay $0 for FreeStyle Libre systems than any other CGMs#4.

See cost and coverage

MyFreeStyle

Ready to get started with a FREE** trial?

Sign up for the MyFreeStyle program to try one of the FreeStyle Libre CGM systems at no cost**.

Go to MyFreeStyle

The FreeStyle Libre 3 system and FreeStyle Libre 2 system are indicated for use in people with diabetes age 4 and older.

Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.

* Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 2 and Freestyle Libre 3 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.

† Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first twelve hours.

‡ The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.

§ 60-minute warm-up required when starting the sensor.

II Study was performed with the outside US version of the FreeStyle Libre 2 system. Data is applicable to FreeStyle Libre 3 system, as feature sets are similar.

¶ Based on a comparison of list prices of the FreeStyle Libre personal CGM systems versus competitors’ CGM systems, assuming annual use of one receiver (or equivalent hardware) and quantity of transmitters and/or sensors according to use life. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.

# Based on prescription claims for the aggregate of patients covered by Commercial insurance, Managed Medicare, Managed Medicaid using the FreeStyle Libre personal CGM systems versus competitors’ CGM systems. Does not include fee-for-service Medicare, fee-for-service Medicaid, and uninsured patients. The actual amount a patient pays may vary. The FreeStyle Libre personal CGM systems requires a prescription.

** or ♢ Eligible patients will receive one (1) FreeStyle Libre 2 system sensor or (1) FreeStyle Libre 3 system sensor for users with a compatible mobile phone operating system at $0 copay. The expiration date of the voucher is 60 days from the issue date. This program is available for patients with Type 1 diabetes or Type 2 diabetes or gestational diabetes. Patients ages 18 and older are eligible to sign up and receive an offer for the (1) FreeStyle Libre 2 system sensor or (1) FreeStyle Libre 3 system sensor. Patients ages 4-17 are eligible to receive an offer for the (1) FreeStyle Libre 2 sensor or (1) FreeStyle Libre 3 sensor through their parent or guardian. Patients ages 2-17 are eligible to receive an offer for the (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor through their parent or guardian. This offer is void where prohibited by law. Abbott may modify or rescind this offer at any time without notice. The discounts are not available to beneficiaries of Kaiser Permanente, Medicare, Medicaid or other federal or state healthcare programs, residents of Massachusetts, or US territories (other than Puerto Rico). The free (1) FreeStyle Libre 2 system sensor or (1) FreeStyle Libre 3 system sensor is provided as a sample and is limited to one sample per eligible person per product identification number. The FreeStyle Libre 2 system sensor or FreeStyle Libre 3 system sensor cannot be re-sold, traded nor submitted to any third-party payer for reimbursement and is not provided as any inducement for future purchases. The free sample card is not health insurance.

References: 1. Fokkert, Marion, et al. "Improved Well-Being and Decreased Disease Burden After 1-Year Use of Flash Glucose Monitoring (FLARE-NL4)." BMJ Open Diabetes Research and Care 7, no.1.(2019): e000809. https://doi.org/10.1136/bmjdrc-2019-000809. 2. Evans, Mark, Zoë Welsh, and Alexander Seibold. "Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for Up to 24 Months: a Meta-analysis of 75 Real-World Observational Studies." Diabetes Therapy 13, no. 6 (2022): 1175-1185. https://doi.org/10.1007/s13300-022-01253-9. 3. Leelarathna, Lalantha, et al. "Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes." New England Journal of Medicine 387, no. 16 (2022): 1477-1487. https://doi.org/10.1056/nejmoa2205650. 4. Data on file. Abbott Diabetes Care, Inc.

ADC-36558 v4.0